Keytruda And The Surprising Fruits Of M&A

Similar fruits can grow in the most disparate soils. So it would seem when one considers the origins of Keytruda and Opdivo, the twin shining stars in the modern immuno-oncology firmament, owned by Merck and Co and Bristol-Myers Squibb, respectively.